Behavioral Weight Loss for Cancer Survivors in Maryland: A Trial With Adaptive Interventions
Helpline
Scaling up Behavioral Weight Loss Opportunities for Cancer Survivors With Overweight or Obesity in Maryland: A Randomized Trial With Adaptive Interventions (Helpline for Weight Loss)
1 other identifier
interventional
200
1 country
1
Brief Summary
The objective of the HELPLINE Weight Loss Program is to determine the comparative effectiveness of two active multi-component, augmented interventions for cancer survivors with overweight or obesity who do not achieve early weight loss goal in the initial intervention period (termed, early non-responders). The core study design is randomized controlled trial with adaptive intervention.
- 1.CORE Helpline in all participants (first 2 months)
- 2.Extended Helpline in early responders (additional 6 months)
- 3.Enhanced Helpline in early non-responders (additional 6 months)
- 4.Intensive Helpline in early non-responders (additional 6 months)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 12, 2024
CompletedFirst Posted
Study publicly available on registry
June 17, 2024
CompletedStudy Start
First participant enrolled
June 17, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
July 20, 2025
July 1, 2025
2.5 years
June 12, 2024
July 16, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Weight (pounds) changes at 8 months from 2-month between Enhanced Helpline and Intensive Helpline arms
Weight change for Enhanced Helpline and Intensive Helpline in early non-responders
8 months
Secondary Outcomes (1)
Weight (pounds) change at 5 and 12 months from 2-month between Enhanced Helpline and Intensive Helpline arms
12 months
Other Outcomes (2)
Weight (pounds) change from baseline to 2 months in all participants
2 months
Within-program weight (pounds) changes from baseline to 5, 8, and 12 months in all programs
12 months
Study Arms (4)
Intensive Helpline
EXPERIMENTALParticipants receive 2 scheduled coaching calls/month and individualized coach-scripted feedback via emails twice/month for 6 months.
Enhanced Helpline
ACTIVE COMPARATORParticipants receive 1 participant-initiated call/month. Additionally, the participants receive individualized coach-scripted feedback via emails twice/month for 6 months
Extended Helpline
OTHERParticipants who achieved 2% weight loss at 2-month, will continue to Extended Helpline, where the participants can continue receiving 1-on-1 coaching through 1 participant-initiated calls per month for 6 months.
CORE Helpline
OTHERAll participants will receive the CORE Helpline program for 2 months
Interventions
All participants will receive the Core Helpline program (CORE) for 2 months, which includes written weight loss material, use of a smartphone app, weekly text messages and email reminders and 1 optional participant-initiated coaching call per month.
Those who achieved 2% weight loss at 2-month, will continue to Extended Helpline, where the participants can continue receiving all CORE resources including1-on-1 coaching through 1 optional participant-initiated call per month for 6 months.
Those who do not reach 2% weight loss at the end of 2 months will be randomized. Participants will continue to receive all CORE resources plus 1 optional participant-initiated call/month for 6 months. Additionally, the participants will receive 2 individualized coach-scripted feedback emails per month, and the option to receive daily text message reminders.
Those who do not reach 2% weight loss at the end of 2 months will be randomized. Participants will continue to receive all CORE resources plus 2 scheduled coaching calls/month for 6 months. Additionally, the participants will receive 2 individual coach-scripted feedback emails per month, and the option to receive daily text message reminders.
Eligibility Criteria
You may qualify if:
- Women and men ages 18 or older
- Able to complete all study requirements in English
- Have been previously diagnosed with a malignant solid tumor, completed the required surgical, and/or chemotherapy and/or radiation curative intent therapy at least three months prior to enrollment, and have an anticipated treatment-free life span of 12 months or longer. Chemoprophylaxis with tamoxifen or aromatase inhibitors for breast cancer in women and anti- luteinizing hormone-releasing hormone (LHRH) therapy for prostate cancer in men will be permitted.
- Have a BMI ≥ 27 kg/m2 (BMI ≥ 25 kg/m2 for Asians) and weight ≤ 400 lbs.
- Have an email address for regular personal use
- Have a smartphone for personal use, and are willing to use the phone to read emails and text messages, and use an app
- Have adequate data plan and cell service to support daily use of weight loss app, receive text messages and to support coaching calls
- Are willing to record weekly weights
- Are willing to use a tracking app to log food and exercise daily
- Are willing to complete coaching calls as planned
- Are willing to prioritize weight loss efforts by making dietary changes and increasing physical activity
You may not qualify if:
- Received any chemotherapy (unless anti-hormonal therapy) and/or radiation three months or less prior to the proposed program date
- Women who are breastfeeding, pregnant, or planning pregnancy within the next year
- self-identification of uncontrolled concurrent medical condition likely to limit compliance with the program as determined by investigators.
- current involvement in another organized weight loss program
- current use of medications known to substantially affect body weight, including chronic oral steroids, Tirzepatide (Mounjaro™), and weight loss doses of other glucagon-like peptide 1 (GLP-1) agonists (e.g. Wegovy.)
- bariatric surgery scheduled within the next 12 months
- plan to move outside the continental United States in the next 12 months
- Weight loss or gain of \>5.0% of body weight during 2 months prior to screening
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Johns Hopkins ProHealth
Baltimore, Maryland, 21207, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jessica Yeh, PhD
Johns Hopkins University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 12, 2024
First Posted
June 17, 2024
Study Start
June 17, 2024
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2027
Last Updated
July 20, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share